Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alevtina M. Orlova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reliability of using the method of immunochromatographic analysis to determine benzodiazepine receptor agonists in the diagnosis of acute poisoning

    by A. A. Vоlkova, R. A. Kаlekin, A. M. Orlova, S. S. Barseghyan

    The immunochromatographic method (ICA) is widely used as a representative and screening study for forensic chemical and chemical-toxicological analysis. The method used has advantages and disadvantages. The disadvantages include both false positive and false negative results. A study was conducted on the detection of benzodiazepine receptor agonists of different chemical structures by the IHA method, the results of which have significant negative results on zaleplon and zopiclone. When tested for clobazam, the result is positive for benzodiazepines, and for phenazepam, it gives a false negative result when detected for a group of benzodiazepines.

  • Retracted

    Identification of markers of ricin-containing object consumption in blood and urine

    by Samvel S. Barsegyan, Roman A. Kalekin, Alla A. Volkova, Alevtina M. Orlova

    Background: The determination of acute and fatal poisoning caused by cytotoxic substances remains a critical issue in forensic medical examination. Ricin belongs to this group of substances and is its most toxic representative. It may cause irreversible health consequences in the human body. Aim: To develop a rapid analysis method for detecting marker substances to establish ricin poisoning in biological samples for forensic medical purposes. Materials and methods: The study describes optimal conditions for the isolation of ricinine and ricinoleic acid as marker substances indicating the presence of ricin. The extraction process was examined in blood and urine. The study utilized advanced chromatographic techniques, including high-performance liquid chromatography (HPLC) and gas chromatography (GC) combined with tandem mass spectrometry (MS/MS). Results: Based on the study findings, a rapid method for detecting ricinine and ricinoleic acid in biological fluids was developed, requiring only 200 µL of biological material. Chromatographic and mass spectrometric characteristics for the identification of ricinine and ricinoleic acid were determined. The presence of toxic ricinine was confirmed in processed products of castor bean (Ricinus communis) seeds, which may pose a risk of human poisoning. Conclusion: The study presents an express method for forensic chemical and toxicological investigation of ricin poisoning using chromatographic techniques — high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) and gas chromatography combined with tandem mass spectrometry (GC-MS/MS). This method is based on the detection of marker substances, ricinine and ricinoleic acid, in biological samples.

  • Forensic chemical and chemicotoxicological examination of ricin poisoning by the HPLC-MS/MS method

    by R.A. Kalekin, S.S. Barseghyan, A.A. Volkova, A.M. Orlova, V.D. Akimova

    The aim of the study is to suggest the method of ricin determination in biological liquids during forensic medical and chemicotoxicological examination. This research describes the optimal conditions of sample processing of biological liquids, allowing to extract the components (ricinine and ricinoleic acid) of castor seeds. The recommended analysis conditions allow to perform research for 15 minutes by high resolution mass spectrometry method combined with high-value liquid chromatography on a chromato-mass spectrometer to detect ricinine and ricinoleic acid. The chromatographic (retention time) and mass-spectrometric parameters (mass spectra) were established for the exact high-quality determination of ricinine and ricinoleic acid.


  • Measurement of benzodiazepine receptor agonists metabolites and their concentration in urine

    by A.A. Volkova, R.A. Kalyokin, A.M. Orlova, O.G. Astashkina, A.Z. Pavlova

    The study objective was to detect and measure the ratio of metabolites of benzodiazepine receptor agonists in urine during forensic chemical and chemical and toxicological studies, as well as to characterize the main metabolites to use them to confirm the oral intake of the test substances. Data on the presence of metabolites in the urine will allow us to reliably confirm the intake of zaleplon, zopiclone, clobazam, and phenazepam and determine the routes of administration (intake) into the body of the victim. Benzodiazepine derivatives (clobazam and phenazepam) and non-benzodiazepines (zaleplon and zopiclone) have different chemical structures and similar mechanisms of action resulting in a similar clinical presentation of side effects and the need for forensic chemical study according to poisoning symptoms. Metabolites of benzodiazepine receptor agonists and their ratio in urine after oral administration were measured: zaleplon (parent compound), deethylzaleplon, 5-oxozaleplon, 5-oxodeethylzaleplon, oxozaleplon glucuronide; zopiclone (parent compound), zopiclone-N-oxide, N-desmethylzopiclone; clobazam (parent compound), N-desmethylclobazam, 4-hydroxyclobazam, hydroxydesmethylclobazam; phenazepam (parent compound) and 3-hydroxyphenazepam. It is advisable to determine zaleplon in urine by the presence of 5-oxaleplon (97% of the total amount of metabolites), zopiclone by zopiclone-N-oxide (86% in urine), clobazam by the parent compound (61% in urine), phenazepam by the parent compound (90—100% in urine).

  • Open Access

    Detection of clobazam and its metabolites in urine during poisoning using HPLC-QqQ-MS/MS

    by Alla A. Volkova, Roman A. Kalekin, Alevtina M. Orlova

    BACKGROUND: Determining the incidence of acute and lethal poisoning with clobazam remains an urgent task of analytical toxicology. The medicinal substance clobazam belongs to the group of benzodiazepines, which is included in the list of psychoactive substances whose turnover is limited because of its high toxicity profile in overdose and abuse. AIM: To propose a simple, reliable, and sensitive technique for the identification of clobazam and its metabolite in the urine by the modern high-performance liquid chromatography-tandem mass spectrometry (HPLC-QqQ-MS/MS). MATERIALS AND METHODS: We have described a simple and sensitive HPLC-QqQ-MS/MS method for the qualitative determination of clobazam in the urine. RESULTS: The retention time in the selected chromatography conditions for clobazam was 5.17 min, and its metabolite (norclobazam) in urine was 4.56 min. The base peaks for clobazam and norclobazam were 259 m/z and 245 m/z, respectively. CONCLUSION: For the first time, this study provides a validated method of chemical-toxicological examination for poisoning with clobazam by HPLC-MS/MS, tested both on a model mixture and real biological matrix of the patients urine after taking clobazam. This technique can be a confirmatory research method in addition to the clinical picture in forensic medical examination.


  • Potential for the use of cards for sampling and transportation of biological material during forensic chemical and toxicological examinations

    by A.A. Volkova, R.A. Kalyokin, A.M. Orlova, O.G. Astashkina

    The objective of the study is to evaluate the potential for the use of cards for sampling and transportation of biological material during forensic chemical and toxicological examinations by the example of a biological sample, urine containing zopiclone. Two methods of sample preparation were compared. The use of cards for the collection and transportation of biological material, such as urine, followed by high-resolution high-performance liquid chromatography-mass spectrometry (HPLC-MS) for the identification of zopiclone metabolites was shown to be beneficial in forensic chemical and toxicological examination. The validation evaluation of the proposed sample preparation and identification method met the acceptance criteria.

  • Determination of zaleplon and clobazam by high performance liquid chromatography — high resolution tandem mass spectrometry using Orbitrap technology

    by R.A. Kalyokin, N.E. Moskaleva, A.A. Volkova, A.M. Orlova, P.A. Markin, S.R. Nevmyatova, S.A. Appolonova

    Was to develop a method for the qualitative and quantitative determination of benzodiazepine receptor agonists (zaleplon and clobazam), taking into account different chemical structures, by high-performance liquid chromatography-high-resolution tandem mass spectrometry using Orbitrap technology for the purposes and tasks of forensic medical examination. A method has been developed for the identification and quantitative determination of zaleplon and clobazam by high-performance liquid chromatography-high-resolution tandem mass spectrometry using Orbitrap technology. The proposed identification method can be used in the future to form a database of domestic mass spectra for potent and narcotic substances.


  • Analysis of the feasibility of a forensic chemical investigation in clobazam poisoning

    by A.A. Volkova, A.M. Orlova, R.A. Kalekin, S.R. Nevmyatova

    The study objective was to determine the relevance of methods to detect clobazam poisoning during the forensic and chemical toxicological examination. The lack of a systematic approach to clobazam identification and assay as a part of forensic chemical and chemical toxicological analyses was demonstrated. The published data on the study of clobazam in biological objects are inconsistent and incomplete, precluding the conduction of focused forensic chemical and toxicological investigations on biological objects with required validity. Various methods of forensic chemical and toxicological investigation of clobazam in biological objects were studied and presented. Data are presented on various physicochemical test methods (TLC, HPLC, UV spectrometry, GC, and GC-MS) for clobazam detection.